Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Fatigue01:21

Fatigue

787
Fatigue occurs when materials rupture under repeated or fluctuating loads, even at stress levels far below their static breaking strength. It typically results in brittle failure, even for ductile materials. It is a critical consideration in designing machines and structural components subjected to repetitive or varying loads. The nature of these loadings can range from fluctuating loads like unbalanced pump impellers causing vibrations to repeatedly bending a thin steel rod wire back and forth...
787
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

3.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.1K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Cross-bridge Cycle01:26

Cross-bridge Cycle

122.1K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
122.1K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

457
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
457

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultra-low-field MRI for bedside imaging of severe multiple sclerosis.

Journal of neurology·2026
Same author

High-Density Lipoprotein-Specific Phospholipid Efflux (HDL-SPE) Assay in Mice.

Molecular nutrition & food research·2026
Same author

In Reply to Inter-Instrument Imprecision Complements Bias in Evaluating LDL-C Method Performance.

Clinical chemistry·2026
Same author

Editorial for "5 T-Based Glutamate Chemical Exchange Saturation Transfer Imaging for Adult Diffuse Glioma Stratification".

Journal of magnetic resonance imaging : JMRI·2026
Same author

Corrigendum to "Identification of a novel apoB variant in a family exhibiting hypocholesterolemia: Mechanistic insights" [J Clin Lipidol (2026) S1933-2874(26)00045-0, ahead of print].

Journal of clinical lipidology·2026
Same author

Nutrition as Neuroprotection: A Role for the Mediterranean Diet.

Neurology·2026
Same journal

A 57-Year-Old Male With Behavioral Variant Frontotemporal Dementia and MATR3 and NOS3 Mutations.

Annals of clinical and translational neurology·2026
Same journal

Reply to: A Lethal Progressive Neuroinflammation Disguised as MOGAD Revealing a Final Diagnosis of Griscelli Syndrome: Regarding: MOGAD is the Most Common Cause of Isolated Optic Neuritis in Children.

Annals of clinical and translational neurology·2026
Same journal

A Lethal Progressive Neuroinflammation Disguised as MOGAD Revealing a Final Diagnosis of Griscelli Syndrome.

Annals of clinical and translational neurology·2026
Same journal

Long-Term Neurologic Exam Findings in People Diagnosed and Treated During Acute HIV Infection.

Annals of clinical and translational neurology·2026
Same journal

Integrating Time-Adjusted Imaging Instability Into Functional Outcome Prediction After Intracerebral Hemorrhage: Development and Validation of the HAGIV Score.

Annals of clinical and translational neurology·2026
Same journal

Advancing Stroke Clinical Trials Using Community Engagement and Implementation Science Approaches.

Annals of clinical and translational neurology·2026
See all related articles

Related Experiment Video

Updated: Jan 11, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.6K

Frailty Exacerbates Disability in Progressive Multiple Sclerosis.

Taylor R Wicks1, Anna Wolska2, Diala Ghazal1

  • 1Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, New York, USA.

Annals of Clinical and Translational Neurology
|November 14, 2025
PubMed
Summary
This summary is machine-generated.

Frailty is common in severe progressive multiple sclerosis (PMS) and linked to increased disability. Inflammatory and metabolic factors contribute to frailty in PMS patients.

Keywords:
agingfrailtymetabolic dysfunctionprimary progressive multiple sclerosissecondary progressive multiple sclerosis

More Related Videos

Frailty Assessment in an Aging Mouse Model
06:58

Frailty Assessment in an Aging Mouse Model

Published on: September 23, 2025

404
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

17.0K

Related Experiment Videos

Last Updated: Jan 11, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.6K
Frailty Assessment in an Aging Mouse Model
06:58

Frailty Assessment in an Aging Mouse Model

Published on: September 23, 2025

404
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

17.0K

Area of Science:

  • Neurology
  • Immunology
  • Metabolomics

Background:

  • Progressive multiple sclerosis (PMS) is a debilitating neurological disease.
  • Frailty is a significant concern in aging populations and can exacerbate disease severity.
  • Understanding frailty mechanisms in PMS is crucial for patient care.

Purpose of the Study:

  • To evaluate the prevalence and severity of frailty in patients with severe progressive multiple sclerosis (PMS).
  • To investigate the potential underlying mechanisms, including inflammatory and metabolic factors, associated with frailty in PMS.

Main Methods:

  • A prospective, cross-sectional, multicenter study comparing a late severe PMS group (n=53) with a matched control PMS group (n=53).
  • Assessments included neurological status (EDSS), frailty (Edmonton Frail Scale), fatigue (Fatigue Severity Scale), and MRI.
  • Metabolomic profiling (IVX, MVX) and serum biomarkers (sNfL, GFAP, GDF15) were analyzed.

Main Results:

  • The late severe PMS group exhibited significantly higher disability (EDSS) and a greater prevalence and severity of frailty compared to controls.
  • Frailty was positively associated with disability (EDSS) in both PMS groups.
  • In the control PMS group, frailty and EFS correlated with inflammatory vulnerability index (IVX) and metabolic vulnerability index (MVX).

Conclusions:

  • Frailty is a significant clinical issue in severe progressive multiple sclerosis, directly correlating with disease disability.
  • Inflammatory and metabolic vulnerabilities are key underlying mechanisms contributing to frailty in PMS.